Patents by Inventor Milaid Granadillo Rodriguez

Milaid Granadillo Rodriguez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell penetrating peptides and its use fused to biomolecules with therapeutic action
    Patent number: 8673313
    Abstract: The present invention relates to use of a new cell penetrating peptides (CPP) and in particular to the region 32-51 of protein Limulus antilipopolisacárido (LALF) and its analogous. This invention refers to compositions containing these peptides associated to biomolecules with therapeutics properties. This invention consist of compositions comprise the covalent fusion of biomolecules, between this human papillomavirus antigens (HPV) to these CPP for induce a potent immune cellular responses against HPV and HPV protein antigen-exhibiting cells including HPV-associated tumors. The referred compositions are applicable in the pharmaceutical industry as vaccine for therapeutic use in human.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: March 18, 2014
    Assignee: Centro de Ingenieria Genetica y Biotecnologia
    Inventors: Isis del Carmen Torrens Madrazo, Maribel Guerra Vallespi, Milaid Granadillo Rodriguez, Osvaldo Reyes Acosta, Boris Ernesto Acevedo Castro
  • CELL PENETRATING PEPTIDES AND ITS USE FUSED TO BIOMOLECULES WITH THERAPEUTIC ACTION
    Publication number: 20120135021
    Abstract: The present invention relates to use of a new cell penetrating peptides (CPP) and in particular to the region 32-51 of protein Limulus antilipopolisacárido (LALF) and its analogous. This invention refers to compositions containing these peptides associated to biomolecules with therapeutics properties. This invention consist of compositions comprise the covalent fusion of biomolecules, between this human papillomavirus antigens (HPV) to these CPP for induce a potent immune cellular responses against HPV and HPV protein antigen-exhibiting cells including HPV-associated tumors. The referred compositions are applicable in the pharmaceutical industry as vaccine for therapeutic use in human.
    Type: Application
    Filed: July 31, 2008
    Publication date: May 31, 2012
    Inventors: Isis del Carmen Torens Madrazo, Maribel Guerra Vallespi, Milaid Granadillo Rodriguez, Osvaldo Reyes Acosta, Boris Ernesto Acevedo Castro